OncoLab Diagnostics GmbH

Founded

2006

Staff

3

Organization type

RDM biotech/pharma

Region

Vienna

OncoLab Diagnostics aims to contribute substantially to enhancing survival time and quality of life of cancer patients and reducing cancer mortality. We will achieve this by developing, manufacturing and marketing highly innovative and utmost precise cancer tests based on circulating tumor cells and a patient’s immune response. R&D focuses on new strategies and technologies to diagnose cancer at much earlier stages than it is possible today. Diagnostic tests will guide treatment options timely.

R&D:Development of in vitro diagnostic tests based on gene expression signatures for early detection of ovarian, breast and pancreatic cancer Development of in vitro diagnostic tests based on gene expression biomarkers for therapy and post-therapy monitoring as well as early detection of relapse for ovarian, breast, endometrial, cervical, and lung cancer.